Literature DB >> 16258368

Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement.

Daniel S Longnecker1, N Volkan Adsay, Carlos Fernandez-del Castillo, Ralph H Hruban, Tsutomu Kasugai, David S Klimstra, Günter Klöppel, Jutta Lüttges, Vincent A Memoli, Tor D Tosteson, Akio Yanagisawa, Robb Wilentz, Giuseppe Zamboni.   

Abstract

OBJECTIVES: The goal of this study was to evaluate the consistency of distinction between pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) and the hypothesis that guidelines for their distinction might be inadequate.
METHODS: A group of 93 pancreas specimens from surgical resections or autopsies that contained lesions consistent with histopathological diagnoses of PanIN-1A, PanIN-1B, PanIN-2, or IPMN (adenoma or borderline) was collected. The classification of these neoplasms by 6 pathologists, 2 from Europe, 2 from Japan, and 2 from the United States, was compared. The pathologists initially used guidelines current in their practice and then reviewed 47 of the 93 specimens a second time using new consensus definitions and guidelines for PanIN and IPMN that were developed in 2003.
RESULTS: The initial comparison showed frequent disagreement regarding both category and grade of the lesions. Agreement was greater for category than grade. In the second review, agreement among the 6 reviewers improved, remaining higher for category, although disagreements persisted for both category and grade.
CONCLUSIONS: We conclude that the new definitions of PanIN and IPMN improve the consistency in classifying these lesions, but additional work is needed to further improve the reproducibility of their classification.

Entities:  

Mesh:

Year:  2005        PMID: 16258368     DOI: 10.1097/01.mpa.0000186245.35716.18

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  31 in total

1.  Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.

Authors:  Dae Wook Hwang; Jin-Young Jang; Seung Eun Lee; Chang-Sup Lim; Kuhn Uk Lee; Sun-Whe Kim
Journal:  Langenbecks Arch Surg       Date:  2010-07-18       Impact factor: 3.445

2.  Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.

Authors:  Kimberly H Allison; Mara H Rendi; Sue Peacock; Tom Morgan; Joann G Elmore; Donald L Weaver
Journal:  Histopathology       Date:  2016-09-23       Impact factor: 5.087

3.  Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study.

Authors:  Kaye M Reid-Lombardo; Jennifer St Sauver; Zhuo Li; William A Ahrens; K Krishnan Unni; Florencia G Que
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

Review 4.  Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Marina Paini; Stefano Crippa; Stefano Partelli; Filippo Scopelliti; Domenico Tamburrino; Andrea Baldoni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 5.  Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Víctor M Castellano-Megías; Carolina Ibarrola-de Andrés; Guadalupe López-Alonso; Francisco Colina-Ruizdelgado
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

Review 6.  Early detection and prevention of pancreatic cancer: is it really possible today?

Authors:  Marco Del Chiaro; Ralf Segersvärd; Matthias Lohr; Caroline Verbeke
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 7.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

8.  Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Seung-Mo Hong; David Kelly; Margaret Griffith; Noriyuki Omura; Ang Li; Chung-Pin Li; Ralph H Hruban; Michael Goggins
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

9.  PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.

Authors:  Frank Schönleben; Wanglong Qiu; Helen E Remotti; Werner Hohenberger; Gloria H Su
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

10.  LIM only 4 is overexpressed in late stage pancreas cancer.

Authors:  Jun Yu; Kenoki Ohuchida; Kohei Nakata; Kazuhiro Mizumoto; Lin Cui; Hayato Fujita; Hiroshi Yamaguchi; Takuya Egami; Hidehisa Kitada; Masao Tanaka
Journal:  Mol Cancer       Date:  2008-12-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.